The Chemical Synthesis Backbone: Understanding tert-Butyl 4-Chlorophenyl Ether
The compound’s structure, featuring a chlorobenzene core with a tert-butoxy group, provides a unique chemical profile. This allows it to act as a reliable reagent in various synthetic pathways. For instance, its use in preparing p-tert-butoxystyrene is critical for producing pharmaceuticals, agrochemicals, and specialty monomers. The efficiency of these synthesis routes is directly linked to the quality and purity of the intermediate. Therefore, when considering to buy tert-Butyl 4-Chlorophenyl Ether, meticulous attention to supplier reliability is essential.
Beyond its primary synthetic applications, CAS 18995-35-2 has also found utility in computational studies, particularly in predicting drug-induced myelotoxicity. This dual applicability highlights its broad importance in scientific research and industrial development. For manufacturers and researchers, identifying a dependable manufacturer such as NINGBO INNO PHARMCHEM CO.,LTD. ensures access to a consistent supply of this vital chemical intermediate, facilitating seamless project execution.
When evaluating suppliers for tert-Butyl 4-Chlorophenyl Ether, consider factors like product specifications, batch-to-batch consistency, and the supplier's adherence to quality standards. The price of the chemical is also a consideration, but it should be weighed against the assurance of quality and reliability. Establishing a strong partnership with a trusted supplier is key to optimizing chemical synthesis processes and achieving desired product outcomes.
Perspectives & Insights
Future Origin 2025
“Beyond its primary synthetic applications, CAS 18995-35-2 has also found utility in computational studies, particularly in predicting drug-induced myelotoxicity.”
Core Analyst 01
“This dual applicability highlights its broad importance in scientific research and industrial development.”
Silicon Seeker One
“For manufacturers and researchers, identifying a dependable manufacturer such as NINGBO INNO PHARMCHEM CO.”